US Stock MarketDetailed Quotes

PLXPQ PLx Pharma

Watchlist

0.000001
0.0000000.00%

15min DelayClose Oct 2 16:00 ET

29.14Market Cap0.00P/E (TTM)

PLx Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

(FY)Dec 31, 2021

(Q4)Dec 31, 2021

(Q3)Sep 30, 2021

(Q2)Jun 30, 2021

(Q1)Mar 31, 2021

(FY)Dec 31, 2020

(Q4)Dec 31, 2020

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-22.05%-10.98M

-230.45%-18.1M

-294.51%-16.89M

-162.34%-32.12M

-430.32%-13.36M

-188.11%-9M

-93.82%-5.48M

-13.44%-4.28M

3.29%-12.24M

30.72%-2.52M

Net income from continuing operations

60.74%-8.5M

28.16%-11.86M

6.54%-10.79M

-203.23%-46.13M

144.63%3.56M

-592.21%-21.64M

-194.79%-16.51M

-871.35%-11.54M

25.81%-15.21M

-299.07%-7.98M

Operating gains losses

-118.86%-2.22M

-126.10%-2.65M

-193.03%-7.41M

230.51%5.49M

-674.54%-24.41M

13,996.03%11.78M

426.59%10.16M

273.14%7.96M

-70.96%1.66M

327.07%4.25M

Depreciation and amortization

-20.55%58K

357.89%49K

-46.15%56K

-48.80%213K

-46.30%55K

-31.76%73K

-118.15%-19K

2.02%104K

64.67%416K

-9.68%102.42K

Other non cash items

----

-96.74%3K

--0

-91.42%3K

-57.27%92K

-74.28%11.02K

Change In working capital

-5,156.52%-2.33M

-1,606.33%-5M

111.26%156K

1,202.65%5.41M

904.43%6.42M

109.34%46K

-25.07%332K

-28.13%-1.39M

-163.21%-491K

429.57%639.27K

-Change in receivables

110.76%350K

--209K

---64K

-3,442.11%-635K

825,767.51%2.62M

---3.25M

--0

4,331.63%19K

101.70%317

-Change in inventory

79.09%-194K

68.19%-356K

---1.38M

-1,506.94%-2.31M

-42,964.52%-267K

---928K

---1.12M

--0

---144K

---620

-Change in prepaid assets

460.00%306K

-140.58%-664K

102.90%280K

-709.46%-599K

-6,066.97%-376K

-362.61%-85K

-140.12%-276K

840.63%138K

-148.46%-74K

52.75%-6.1K

-Change in payables and accrued expense

-162.79%-2.76M

-347.04%-4.17M

193.87%1.35M

70,046.15%9.12M

516.63%4.47M

1,082.05%4.39M

117.98%1.69M

-38.09%-1.44M

-98.23%13K

1,022.93%725.23K

-Change in other current liabilities

64.63%-29K

-151.28%-20K

70.45%-26K

48.52%-157K

67.32%-26K

-6.06%-82K

151.65%39K

-21.20%-88K

-177.99%-305K

5.06%-79.57K

Cash from discontinued investing activities

Operating cash flow

-22.05%-10.98M

-230.45%-18.1M

-294.51%-16.89M

-162.34%-32.12M

-430.32%-13.36M

-188.11%-9M

-93.82%-5.48M

-13.44%-4.28M

3.29%-12.24M

30.72%-2.52M

Investing cash flow

Cash flow from continuing investing activities

193.14%95K

148.04%49K

55.71%-102K

Net PPE purchase and sale

--0

----

193.14%95K

--1K

148.04%49K

----

55.71%-102K

--0

Cash from discontinued investing activities

Investing cash flow

--0

----

193.14%95K

--1K

148.04%49K

----

55.71%-102K

--0

Financing cash flow

Cash flow from continuing financing activities

-90.42%1.09M

12.90%1.33M

279.77%78.97M

-98.75%198K

1,298.54%11.33M

-82.66%1.18M

7,167.41%66.26M

64.50%20.79M

2,147.47%15.88M

Net issuance payments of debt

--0

83.33%-625K

--0

33.33%-625K

-20.00%-3.75M

0.00%-937.5K

Net common stock issuance

-85.67%1.09M

--1.33M

--0

342.83%74.48M

--23K

--7.58M

--0

--66.88M

699.51%16.82M

----

Net preferred stock issuance

----

--0

----

-43.47%7.72M

---312

Proceeds from stock option exercised by employees

--0

----

--5.11M

--175K

--3.75M

----

--0

----

Cash from discontinued financing activities

Financing cash flow

-90.42%1.09M

12.90%1.33M

--0

279.77%78.97M

-98.75%198K

1,298.54%11.33M

-82.66%1.18M

7,167.41%66.26M

64.50%20.79M

2,147.47%15.88M

Net cash flow

Beginning cash position

-55.43%35.73M

-37.82%52.5M

209.11%69.39M

60.34%22.45M

808.53%82.55M

504.73%80.17M

809.08%84.42M

60.34%22.45M

-1.75%14M

-50.91%9.09M

Current changes in cash

-515.10%-9.9M

-294.19%-16.77M

-127.26%-16.89M

455.67%46.94M

-198.50%-13.16M

157.16%2.38M

-207.14%-4.25M

1,414.55%61.98M

3,493.28%8.45M

396.41%13.36M

End cash Position

-68.71%25.83M

-55.43%35.73M

-37.82%52.5M

209.11%69.39M

808.53%82.55M

504.73%80.17M

809.08%84.42M

60.34%22.45M

Free cash flow

-22.05%-10.98M

-230.45%-18.1M

-294.51%-16.89M

-160.17%-32.12M

-430.32%-13.36M

-179.00%-9M

-93.98%-5.48M

-13.37%-4.28M

4.31%-12.35M

32.50%-2.52M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022	(FY)Dec 31, 2021	(Q4)Dec 31, 2021	(Q3)Sep 30, 2021	(Q2)Jun 30, 2021	(Q1)Mar 31, 2021	(FY)Dec 31, 2020	(Q4)Dec 31, 2020
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-22.05%-10.98M	-230.45%-18.1M	-294.51%-16.89M	-162.34%-32.12M	-430.32%-13.36M	-188.11%-9M	-93.82%-5.48M	-13.44%-4.28M	3.29%-12.24M	30.72%-2.52M
Net income from continuing operations	60.74%-8.5M	28.16%-11.86M	6.54%-10.79M	-203.23%-46.13M	144.63%3.56M	-592.21%-21.64M	-194.79%-16.51M	-871.35%-11.54M	25.81%-15.21M	-299.07%-7.98M
Operating gains losses	-118.86%-2.22M	-126.10%-2.65M	-193.03%-7.41M	230.51%5.49M	-674.54%-24.41M	13,996.03%11.78M	426.59%10.16M	273.14%7.96M	-70.96%1.66M	327.07%4.25M
Depreciation and amortization	-20.55%58K	357.89%49K	-46.15%56K	-48.80%213K	-46.30%55K	-31.76%73K	-118.15%-19K	2.02%104K	64.67%416K	-9.68%102.42K
Other non cash items	----	----	----	-96.74%3K	--0	--0	--0	-91.42%3K	-57.27%92K	-74.28%11.02K
Change In working capital	-5,156.52%-2.33M	-1,606.33%-5M	111.26%156K	1,202.65%5.41M	904.43%6.42M	109.34%46K	-25.07%332K	-28.13%-1.39M	-163.21%-491K	429.57%639.27K
-Change in receivables	110.76%350K	--209K	---64K	-3,442.11%-635K	825,767.51%2.62M	---3.25M	--0	--0	4,331.63%19K	101.70%317
-Change in inventory	79.09%-194K	68.19%-356K	---1.38M	-1,506.94%-2.31M	-42,964.52%-267K	---928K	---1.12M	--0	---144K	---620
-Change in prepaid assets	460.00%306K	-140.58%-664K	102.90%280K	-709.46%-599K	-6,066.97%-376K	-362.61%-85K	-140.12%-276K	840.63%138K	-148.46%-74K	52.75%-6.1K
-Change in payables and accrued expense	-162.79%-2.76M	-347.04%-4.17M	193.87%1.35M	70,046.15%9.12M	516.63%4.47M	1,082.05%4.39M	117.98%1.69M	-38.09%-1.44M	-98.23%13K	1,022.93%725.23K
-Change in other current liabilities	64.63%-29K	-151.28%-20K	70.45%-26K	48.52%-157K	67.32%-26K	-6.06%-82K	151.65%39K	-21.20%-88K	-177.99%-305K	5.06%-79.57K
Cash from discontinued investing activities
Operating cash flow	-22.05%-10.98M	-230.45%-18.1M	-294.51%-16.89M	-162.34%-32.12M	-430.32%-13.36M	-188.11%-9M	-93.82%-5.48M	-13.44%-4.28M	3.29%-12.24M	30.72%-2.52M
Investing cash flow
Cash flow from continuing investing activities	0			193.14%95K	1K	148.04%49K			55.71%-102K	0
Net PPE purchase and sale	--0	----	----	193.14%95K	--1K	148.04%49K	----	----	55.71%-102K	--0
Cash from discontinued investing activities
Investing cash flow	--0	----	----	193.14%95K	--1K	148.04%49K	----	----	55.71%-102K	--0
Financing cash flow
Cash flow from continuing financing activities	-90.42%1.09M	12.90%1.33M	0	279.77%78.97M	-98.75%198K	1,298.54%11.33M	-82.66%1.18M	7,167.41%66.26M	64.50%20.79M	2,147.47%15.88M
Net issuance payments of debt	--0	--0	--0	83.33%-625K	--0	--0	--0	33.33%-625K	-20.00%-3.75M	0.00%-937.5K
Net common stock issuance	-85.67%1.09M	--1.33M	--0	342.83%74.48M	--23K	--7.58M	--0	--66.88M	699.51%16.82M	----
Net preferred stock issuance	----	----	----	--0	----	----	----	----	-43.47%7.72M	---312
Proceeds from stock option exercised by employees	--0	----	----	--5.11M	--175K	--3.75M	----	----	--0	----
Cash from discontinued financing activities
Financing cash flow	-90.42%1.09M	12.90%1.33M	--0	279.77%78.97M	-98.75%198K	1,298.54%11.33M	-82.66%1.18M	7,167.41%66.26M	64.50%20.79M	2,147.47%15.88M
Net cash flow
Beginning cash position	-55.43%35.73M	-37.82%52.5M	209.11%69.39M	60.34%22.45M	808.53%82.55M	504.73%80.17M	809.08%84.42M	60.34%22.45M	-1.75%14M	-50.91%9.09M
Current changes in cash	-515.10%-9.9M	-294.19%-16.77M	-127.26%-16.89M	455.67%46.94M	-198.50%-13.16M	157.16%2.38M	-207.14%-4.25M	1,414.55%61.98M	3,493.28%8.45M	396.41%13.36M
End cash Position	-68.71%25.83M	-55.43%35.73M	-37.82%52.5M	209.11%69.39M	209.11%69.39M	808.53%82.55M	504.73%80.17M	809.08%84.42M	60.34%22.45M	60.34%22.45M
Free cash flow	-22.05%-10.98M	-230.45%-18.1M	-294.51%-16.89M	-160.17%-32.12M	-430.32%-13.36M	-179.00%-9M	-93.98%-5.48M	-13.37%-4.28M	4.31%-12.35M	32.50%-2.52M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall